Clinical Trial Update: Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1 [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update comparing an oral weekly islatravir/lenacapavir regimen versus Bictegravir/Emtricitabine/Tenofovir alafenamide in virologically …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Bictegravir (bictegravir)
• Emtricitabine (Emtricitabine)
• Islatravir (Islatravir)
• Lenacapavir (lenacapavir)
• Tenofovir alafenamide (tenofovir alafenamide)

Snippet

Sponsor: Gilead Sciences | Conditions: HIV-1-infection | Phase 3 | Status: ACTIVE_NOT_RECRUITING